HK

Hardikkumar Kamleshbhai Seta

Active Director Designated Partner DIN 10967188
DIN 10967188 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hardikkumar Kamleshbhai Seta

Data last updated:

Hardikkumar Kamleshbhai Seta is a Designated Partner at Medilyx Drugs & Chem Llp (since 2025).

DIN 10967188
Primary Designation Designated Partner
First Appointment 24 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Feb 20252025Active

Board colleagues of Hardikkumar Kamleshbhai Seta

NameDINCompanyDesignation
Meet Milanbhai Yagnik10967186Medilyx Drugs & Chem LlpDesignated Partner
Monil Kamlesh Seta10967187Medilyx Drugs & Chem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medilyx Drugs & Chem Llp
Premium access

Shareholding and investment profile for Hardikkumar Kamleshbhai Seta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardikkumar Kamleshbhai Seta

Hardikkumar Kamleshbhai Seta currently holds 1 directorship: Medilyx Drugs & Chem Llp (Designated Partner, since 24 Feb 2025).

Hardikkumar Kamleshbhai Seta was first appointed on 24 Feb 2025 as Designated Partner at Medilyx Drugs & Chem Llp.

The current boards of Hardikkumar Kamleshbhai Seta's companies include Meet Milanbhai Yagnik (Medilyx Drugs & Chem Llp), Monil Kamlesh Seta (Medilyx Drugs & Chem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available